U.S. Supporting Ecological Surveillance for Special Pathogens in Sierra Leone
The U.S. Centers for Disease Control and Prevention has issued a funding opportunity in support of improved vector surveillance and ...
Tag: Marburg
Fundamental Research to Counter Biological, Chemical, and Nuclear Weapons
The Defense Threat Reduction Agency (DTRA) seeks to identify, adopt, and adapt emerging, existing and revolutionary sciences that may demonstrate ...
WHO Updates Blueprint List of Priority Diseases
The 2018 review of the World Health Organization’s Blueprint list of priority diseases occurred February 6-7, 2018. Given their potential ...
Inhibiting PP2A-B56 to Suppress Ebola Virus Transcription and Infection
Researchers from the University of Copenhagen and Phillips Universität Marburg have found a new target for inhibiting Ebola virus from ...
BARDA BAA 2018: Pandemic Influenza, Infectious Diseases, CBRN Countermeasures
The Biomedical Advanced Research and Development Authority (BARDA) is soliciting proposals for the advanced research and development of medical countermeasures ...
NIAID Backs VesiculoVax Vaccine for Ebola, Marburg, and Lassa Viruses
Profectus BioSciences, Inc. has received a contract for up to $22.25 million from the National Institute of Allergy and Infectious ...
Monoclonal Antibody Cures Late-Stage Marburg Infection in Monkeys
A study led by scientists at the University of Texas Medical Branch Galveston National Laboratory and Mapp Biopharmaceutical has found ...
PHEMCE Review: Accomplishments and Future Areas of Opportunity
The United States continues to face national security risks from natural, accidental , and intentional health threats. Efforts to improve ...
GAO Recommendations on Select Agent Program Improvements
The total number of incidents involving incomplete inactivation—a process to destroy the hazardous effects of pathogens while retaining characteristics for ...
Advanced Development of Filovirus and Lassa Fever Vaccines
The National Institute of Allergy and Infectious Diseases (NIAID) is seeking proposals for advanced development of multivalent vaccines against Ebola ...
A Lengthy Arms Race Between Ebola and Bats
Ebola virus and bats have been waging a molecular battle for survival that may have started at least 25 million ...
USAMRIID Seeks Mouse Supply for Filovirus Research
The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), the Department of Defense's lead laboratory for medical biological defense ...
DoD CBRN Medical Countermeasure Consortium
Military program managers briefed biopharmaceutical industry and research organization representatives during a Nov. 2 Industry Day, part of an initiative ...
Handicapping Ebola to Buy Immune System Time to Respond
The Ebola virus acts fast. The course of infection, from exposure to recovery, or death, can take as little as ...
RFI – Vaccine Candidates and Technologies for Filoviruses
The National Institute of Allergy and Infectious Diseases (NIAID) is seeking information from pharmaceutical and biopharmaceutical product developers on multivalent ...
BAA – Medical Countermeasures for Priority Pathogens
The National Institute of Allergy and Infectious Diseases (NIAID) has released a new Broad Agency Announcement (BAA) to support development ...
New Antibody Weapons Against Marburg Virus
Antibodies that identify and neutralize Marburg virus. Credit: TSRI A new study led by scientists at ...
Airport Screening for Viruses Misses Half of Infected Travelers
In the past decade, the H1N1 virus and Ebola are just two of the diseases whose spread was spurred by ...
Llama Antibodies Could Hold Key to Marburg, Ebola Diagnostics
Scientists at Texas Biomedical Research Institute in San Antonio are receiving funding from the National Institutes of Health in the ...
Military Seeks Support for Arenaviruses Countermeasures
The U.S. Army Medical Research Acquisition Activity (USAMRIID) is seeking research services to develop mechanisms of action for FDA-approved drugs ...
Featured Partner
